ACAD vs IONS · P/E 15, rev $576.0M vs rev $514.0M
ACADIA Pharmaceuticals Inc (ACAD) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ACAD and IONS stock pages for the full models.
Not investment advice.